Disseminated on behalf of Quantum BioPharma Ltd., may include paid advertisements. Investment Considerations Proprietary R&D is led by a world-class team of medicinal chemists and industry veterans, ensuring innovative product development. A first-to-market product, unbuzzd addresses a fast-expanding consumer category, with 300% growth expected by 2030. Lucid-MS, a potential multi-billion-dollar asset, represents a significant breakthrough … Continue reading “Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)”
							
							
							| Symbol | Release | Time | 
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |